Abstract
For effective control of foot-and-mouth disease (FMD), the development of rapid diagnostic systems and vaccines are required against its etiological agent, FMD virus (FMDV). To accomplish this, efficient large-scale expression of the FMDV VP1 protein, with high solubility, needs to be optimized. We attempted to produce high levels of a serotype O FMDV VP1 epitope in Escherichia coli. We identified the subtype-independent serotype O FMDV VP1 epitope sequence and used it to construct a glutathione S-transferase (GST) fusion protein. For efficient production of the FMDV VP1 epitope fused to GST (VP1e–GST), four E. coli strains and three temperatures were examined. The conditions yielding the greatest level of VP1e–GST with highest solubility were achieved with E. coli BL21(DE3) at 25 °C. For high-level production, fed-batch cultures were conducted in 5-l bioreactors. When cells were induced at a high density and complex feeding solutions were supplied, approximately 11 g of VP1e–GST was obtained from a 2.9-l culture. Following purification, the VP1 epitope was used to immunize rabbits, and we confirmed that it induced an immune response.
Similar content being viewed by others
References
Burman A, Clark S, Abrescia NG, Fry EE, Stuart DI, Jackson T (2006) Specificity of the VP1 GH loop of Foot-and-Mouth Disease virus for alphav integrins. J Virol 80(19):9798–9810
Carrillo C, Tulman E, Delhon G, Lu Z, Carreno A, Vagnozzi A, Kutish G, Rock D (2005) Comparative genomic of foot-and-mouth disease virus. J Virol Methods 79:6487–6504
Challa S, Barrette R, Rood D, Zinckgraf J, French R, Silbart L (2007) Non-toxic Pseudomonas aeruginosa exotoxin A expressing the FMDV VP1 G-H loop for mucosal vaccination of swine against foot and mouth disease virus. Vaccine 25(17):3328–3337
Chiarella P, Edelmann B, Fazio VM, Sawyer AM, de Marco A (2010) Antigenic features of protein carriers commonly used in immunisation trials. Biotechnol Lett 32(9):1215–1221
Corisdeo S, Wang B (2004) Functional expression and display of an antibody Fab fragment in Escherichia coli: study of vector designs and culture conditions. Protein Expr Purif 34(2):270–279
Crooks GE, Hon G, Chandonia JM, Brenner SE (2004) WebLogo: a sequence logo generator. Genome Res 14(6):1188–1190
Dechamma HJ, Ashok Kumar C, Nagarajan G, Suryanarayana VV (2008) Processing of multimer FMD virus VP1-2A protein expressed in E. coli into monomers. Indian J Exp Biol 46(11):760–763
Domingo E, Pariente N, Airaksinen A, Gonzalez-Lopez C, Sierra S, Herrera M, Grande-Perez A, Lowenstein PR, Manrubia SC, Lazaro E, Escarmis C (2005) Foot-and-mouth disease virus evolution: exploring pathways towards virus extinction. Curr Top Microbiol Immunol 288:149–173
Fowler VL, Bashiruddin JB, Maree FF, Mutowembwa P, Bankowski B, Gibson D, Cox S, Knowles N, Barnett PV (2011) Foot-and-mouth disease marker vaccine: cattle protection with a partial VP1 G-H loop deleted virus antigen. Vaccine 29(46):8405–8411
Fowler VL, Knowles NJ, Paton DJ, Barnett PV (2010) Marker vaccine potential of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion. Vaccine 28(19):3428–3434
Gao SD, Du JZ, Chang HY, Cong GZ, Shao JJ, Lin T, Song S, Xie QG (2010) B cell epitopes within VP1 of type O foot-and-mouth disease virus for detection of viral antibodies. Virol Sin 25(1):18–26
Grubman MJ, Baxt B (2004) Foot-and-mouth disease. Clin Microbiol Rev 17(2):465–493
Hui RK, Leung FC (2012) Evolutionary trend of foot-and-mouth disease virus in Hong Kong. Vet Microbiol 159(1–2):221–229
Jackson T, King A, Stuart D, Fry E (2003) Structure and receptor binding. Virus Res 91:33–46
Jang SH, Lee CH, Kim YS, Jeong KJ (2011) High-level production of a kringle domain variant by high-cell-density cultivation of Escherichia coli. Appl Microbiol Biotechnol 92(2):327–336
Jeong KJ, Choi JH, Yoo WM, Keum KC, Yoo NC, Lee SY, Sung MH (2004) Constitutive production of human leptin by fed-batch culture of recombinant rpoS- Escherichia coli. Protein Expr Purif 36(1):150–156
Jeong KJ, Lee SY (1999) High-level production of human leptin by fed-batch cultivation of recombinant Escherichia coli and its purification. Appl Environ Microbiol 65(7):3027–3032
Jeong KJ, Rani M (2011) High-level production of a single chain antibody against anthrax toxin in Escherichia coli by high cell density cultivation. Bioprocess Biosyst Eng 34(7):811–817
Kim J, Kim S, Nguyen D, Li H, Kim S, Seo Y, Yang J, Chung I, Kim D, Kim C (2009) Production of β-carotene by recombinant Escherichia coli with engineered whole mevalonate pathway in batch and bed-batch cultures. Biotechnol Bioprocess Eng 5:559–564
Li Y, Sun M, Liu J, Yang Z, Zhang Z, Shen G (2006) High expression of foot-and-mouth disease virus structural protein VP1 in tobacco chloroplasts. Plant Cell Rep 25(4):329–333
Liu X, Wang Y, Zhang Y, Fang T, Pan L, Lü J, Zhou P, Zhang Z, Xqi-wei C, Wang G, Wang J, Lou H, Jiang S (2011) Cloning, codon-optimized expression and homology modeling of structural protein VP1 from foot and mouth disease virus. Afr J Microbiol Res 5:486–495
OIE (2011) OIE: Terrestrial animal health code. http://www.oie.int/eng/A_FMD2012/docs/en_chapitre_1.8.5.pdf
Pfaff E, Thiel HJ, Beck E, Strohmaier K, Schaller H (1988) Analysis of neutralizing epitopes on foot-and-mouth disease virus. J Virol 62(6):2033–2040
Sambrook J, Russell D (2001) Molecular cloning: a laboratory manual, 3rd edn. Cold Spring Harbor Laboratory Press, New York
Samuel AR, Knowles NJ (2001) Foot-and-mouth disease type O viruses exhibit genetically and geographically distinct evolutionary lineages (topotypes). J Gen Virol 82(Pt 3):609–621
Shi XJ, Wang B, Zhang C, Wang M (2006) Expressions of Bovine IFN-gamma and foot-and-mouth disease VP1 antigen in P. pastoris and their effects on mouse immune response to FMD antigens. Vaccine 24(1):82–89
Sobrino F, Saiz M, Jimenez-Clavero MA, Nunez JI, Rosas MF, Baranowski E, Ley V (2001) Foot-and-mouth disease virus: a long known virus, but a current threat. Vet Res 32(1):1–30
Strohmaier K, Franze R, Adam KH (1982) Location and characterization of the antigenic portion of the FMDV immunizing protein. J Gen Virol 59(Pt 2):295–306
Subramaniam S, Sanyal A, Mohapatra JK, Hemadri D, Pattnaik B (2011) Comparative complete genome analysis of Indian type A foot-and-mouth disease virus field isolates. Virus Genes 43(2):224–233
van Lierop MJ, Wagenaar JP, van Noort JM, Hensen EJ (1995) Sequences derived from the highly antigenic VP1 region 140 to 160 of foot-and-mouth disease virus do not prime for a bovine T-cell response against intact virus. J Virol 69(7):4511–4514
Waterhouse AM, Procter JB, Martin DM, Clamp M, Barton GJ (2009) Jalview Version 2–a multiple sequence alignment editor and analysis workbench. Bioinformatics 25(9):1189–1191
Wong HT, Cheng SC, Chan EW, Sheng ZT, Yan WY, Zheng ZX, Xie Y (2000) Plasmids encoding foot-and-mouth disease virus VP1 epitopes elicited immune responses in mice and swine and protected swine against viral infection. Virology 278(1):27–35
Zhang ZW, Zhang YG, Wang YL, Pan L, Fang YZ, Jiang ST, Lu JL, Zhou P (2010) Screening and identification of B cell epitopes of structural proteins of foot-and-mouth disease virus serotype Asia1. Vet Microbiol 140(1–2):25–33
Acknowledgments
This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 20120005476).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Jung, JG., Lee, Y.J., Velmurugan, N. et al. High-yield production of the VP1 structural protein epitope from serotype O foot-and-mouth disease virus in Escherichia coli . J Ind Microbiol Biotechnol 40, 705–713 (2013). https://doi.org/10.1007/s10295-013-1273-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10295-013-1273-7